These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 3267306)
21. Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo. Teicher BA; Holden SA; Eder JP; Brann TW; Jones SM; Frei E Cancer Res; 1989 Nov; 49(21):5994-8. PubMed ID: 2790813 [TBL] [Abstract][Full Text] [Related]
22. In vitro evaluation of in vivo brain tumor chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea. Rosenblum ML; Wheeler KT; Wilson CB; Barker M; Knebel KD Cancer Res; 1975 Jun; 35(6):1387-91. PubMed ID: 1131813 [TBL] [Abstract][Full Text] [Related]
23. Cytotoxic effect of the association of BCNU with rhein or lonidamine on a human glioma cell line. Floridi A; Gentile PF; Bruno T; Fanciulli M; Paggi MG; Zeuli M; Benassi M Anticancer Res; 1991; 11(2):789-92. PubMed ID: 1648334 [TBL] [Abstract][Full Text] [Related]
25. Decreased DNA interstrand cross-linking and cytotoxicity induced in human brain tumor cells by 1,3-bis(2-chloroethyl)-1-nitrosourea after in vitro reaction with glutathione. Ali-Osman F; Caughlan J; Gray GS Cancer Res; 1989 Nov; 49(21):5954-8. PubMed ID: 2551496 [TBL] [Abstract][Full Text] [Related]
26. DNA interstrand cross-linking and cytotoxicity induced by chloroethylnitrosoureas and cisplatin in human glioma cell lines which vary in cellular concentration of O6-alkylguanine-DNA alkyltransferase. Beith J; Hartley J; Darling J; Souhami R Br J Cancer; 1997; 75(4):500-5. PubMed ID: 9052400 [TBL] [Abstract][Full Text] [Related]
27. Sister chromatid exchange induction in patients with anaplastic gliomas undergoing treatment with radiation plus diaziquone or 1,3-bis(2-chloroethyl)-1-nitrosourea. Kligerman AD; Erexson GL; Wilmer JL; Schold SC Cancer Res; 1987 Jan; 47(2):631-5. PubMed ID: 3791247 [TBL] [Abstract][Full Text] [Related]
28. Variations in response of human brain tumors to BCNU in vitro. Kornblith PL; Szypko PE J Neurosurg; 1978 Apr; 48(4):580-6. PubMed ID: 632883 [TBL] [Abstract][Full Text] [Related]
29. Brain-tumor therapy. Quantitative analysis using a model system. Rosenblum MK; Knebel KD; Vasquez DA; Wilson CB J Neurosurg; 1977 Feb; 46(2):145-54. PubMed ID: 833632 [TBL] [Abstract][Full Text] [Related]
30. In vitro effects of ACNU, BCNU, CDDP, and bleomycin on human glioma cells. Iwata K; Yung WK; Fields WS Neurol Med Chir (Tokyo); 1988 Oct; 28(10):965-9. PubMed ID: 2462685 [No Abstract] [Full Text] [Related]
31. Preservation of brain tumor specimens for drug sensitivity testing. Kapp JP; Perkins E; Tucker E Neurosurgery; 1989 Jun; 24(6):810-3. PubMed ID: 2747856 [TBL] [Abstract][Full Text] [Related]
32. DNA cross-linking responses of human malignant glioma cell strains to chloroethylnitrosoureas, cisplatin, and diaziquone. Sariban E; Kohn KW; Zlotogorski C; Laurent G; D'Incalci M; Day R; Smith BH; Kornblith PL; Erickson LC Cancer Res; 1987 Aug; 47(15):3988-94. PubMed ID: 3038305 [TBL] [Abstract][Full Text] [Related]
33. Response variability of human brain tumors to AZQ in tissue culture. Kornblith PL; Rosa L; Bona JD; Edwards JA; Matuzic N; Hirschfeld A; Hawkins C J Neurooncol; 1986; 4(1):49-54. PubMed ID: 3746385 [TBL] [Abstract][Full Text] [Related]
34. Potentials and limitations of a clonogenic cell assay for human brain tumors. Rosenblum ML; Dougherty DV; Deen DF; Wilson CB Cancer Treat Rep; 1981; 65 Suppl 2():61-6. PubMed ID: 7346148 [TBL] [Abstract][Full Text] [Related]
35. Enhanced antitumor activity of sarCNU in comparison to BCNU in an extraneuronal monoamine transporter positive human glioma xenograft model. Chen ZP; Wang G; Huang Q; Sun ZF; Zhou LY; Wang AD; Panasci LC J Neurooncol; 1999 Aug; 44(1):7-14. PubMed ID: 10582663 [TBL] [Abstract][Full Text] [Related]
36. A murine model to evaluate the ability of in vitro clonogenic assays to predict the response to tumors in vivo. Mirabelli CK; Sung CM; McCabe FL; Faucette LF; Crooke ST; Johnson RK Cancer Res; 1988 Oct; 48(19):5447-54. PubMed ID: 3046738 [TBL] [Abstract][Full Text] [Related]
37. Chemosensitivity and radiosensitivity of small cell lung cancer cell lines studied by a newly developed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) hybrid assay. Hida T; Ueda R; Takahashi T; Watanabe H; Kato T; Suyama M; Sugiura T; Ariyoshi Y; Takahashi T Cancer Res; 1989 Sep; 49(17):4785-90. PubMed ID: 2547517 [TBL] [Abstract][Full Text] [Related]
38. An analysis of radiotherapy data from the CNS cancer consortium's randomized prospective trial comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumors. The CNS cancer consortium. Halperin EC; Gaspar L; Imperato J; Salter M; Herndon J; Dowling S Am J Clin Oncol; 1993 Aug; 16(4):277-83. PubMed ID: 8392285 [TBL] [Abstract][Full Text] [Related]
39. Utilization of the HTSCA and CFU-C assay to identify two new 2-chloroethylnitrosourea congeners of amino acid amides with increased in vitro activity against human glioma compared with BCNU. Panasci LC; Dufour M; Chevalier L; Isabel G; Lazarus P; McQuillan A; Arbit E; Brem S; Feindel W Cancer Chemother Pharmacol; 1985; 14(2):156-9. PubMed ID: 3971480 [TBL] [Abstract][Full Text] [Related]
40. Age-related chemosensitivity of stem cells from human malignant brain tumours. Rosenblum ML; Gerosa M; Dougherty DV; Reese C; Barger GR; Davis RL; Levin VA; Wilson CB Lancet; 1982 Apr; 1(8277):885-7. PubMed ID: 6122104 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]